Fig. 1: Overview of driver gene mutations identified by targeted sequencing in 100 AML patients | Blood Cancer Journal

Fig. 1: Overview of driver gene mutations identified by targeted sequencing in 100 AML patients

From: Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1

Fig. 1

a Heatmap depicting gene mutations in 100 adult AML patients in the Cleveland Clinic cohort. b Analysis of variant allelic frequencies (VAFs) of driver gene mutations found in ≥5 patients. c Number of driver gene mutations in patients with de novo AML (dnAML) compared with secondary AML (sAML) and treatment-related AML (tAML)

Back to article page